While HER2-enriched and luminal B cancers demonstrated only the upregulation of NF-kappaB transcription factor activity and I-kappaB kinase (IKK)/NF-kappaB signaling, TNBC showed the downregulation of IKK/NF-kappaB signaling as well. Here, ERBB2 is linked to cancer.